Emerging Leaders in Health and Medicine Scholars

Ami S. Bhatt, MD, PhD

Ami S. Bhatt, MD, PhD

Assistant Professor of Medicine (Hematology, BMT) and Genetics; Director of Global Oncology, Center for Innovation in Global Health, Stanford University

Bio

Ami Bhatt is a physician-scientist with a strong interest in microbial genomics and metagenomics. She received her MD and PhD from the University of California, San Francisco. She then carried out her residency and fellowship training at Harvard’s Brigham and Women’s Hospital and Dana-Farber Cancer Institute, and served as Chief Medical Resident from 2010-2011. She joined the faculty of the Departments of Medicine (Divisions of Hematology and Blood & Marrow Transplantation) and Genetics at Stanford University in 2014 after completing a post-doctoral fellowship focused on genomics at the Broad Institute of Harvard and MIT. Prof. Bhatt has received multiple awards for her academic scholarship including the Chen Award of Excellence from the Human Genome Organisation (HUGO).

Her team’s research program seeks to illuminate the interplay between the microbial environment and host/clinical factors in human diseases. Her translational laboratory develops and applies novel molecular and computational tools to study strain level dynamics of the microbiome, to understand how microbial genomes change over time and predict the functional output of microbiomes. These innovations facilitate much improved (1) measurement of the types and functions of microbes in patients with non-communicable diseases, (2) understanding how microbes communicate with one another and with human cells using small proteins, and (3) testing of the impact of microbially targeted interventions in clinical trials.

In addition to carrying out research at Stanford University, Prof. Bhatt has active collaborations worldwide including in Nigeria and South Africa. She is committed to ensuring that advances in research touch the lives of individuals in all income settings–and thus, in her spare time, enjoys volunteering for the nonprofit she co-founded, Global Oncology and serves as the Director for Global Oncology for Stanford’sCenter for Innovation in Global Health.

Maria Elena Bottazzi, PhD

Maria Elena Bottazzi, PhD

Associate Dean, National School of Tropical Medicine Professor, Pediatric Tropical Medicine & Molecular Virology & Microbiology Baylor College of Medicine

Bio

Dr. Maria Elena Bottazzi, Associate Dean of the National School of Tropical Medicine and Professor in Pediatrics and Molecular Virology and Microbiology at Baylor College of Medicine, is an internationally-recognized vaccinologist and global health advocate. As Co-director of Texas Children’s Hospital Center for Vaccine Development, she has more than two decades of experience in applying a product development partnership (PDP) model to build sustainable global biotechnology capacity and training programs that have successfully transitioned NTD vaccines from bench to clinic. Her philosophy is to engage, motivate and empower young scientists to build strong networks and contribute to scientific and global health effectiveness. As a global thought-leader she has received national and international highly regarded awards,has more than 120 scientific papers and participated in more than 200 conferences worldwide. She is a Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH), the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM), the Leshner Leadership Institute Public Engagement (Infectious Diseases) of the American Association for the Advancement of Science (AAAS) and a Sr. Fellow of the American Leadership Forum (ALF). Currently, she is also a committee member to the National Academy of Sciences, Engineering, and Medicine for the Stronger Food and Drug Regulatory Systems Abroad consensus study. Dr. Bottazzi has a bachelor’s degree in Microbiology and Clinical Chemistry from the National Autonomous University in Honduras, and a doctorate in Molecular Immunology and Experimental Pathology from the University of Florida. Her post-doctoral training in Cellular Biology was completed at University of Miami and Pennsylvania.

Brandon Brown, PhD, MPH

Brandon Brown, PhD, MPH

Associate Professor of Medicine, Department of Social Medicine, Population, and Public Health, University of California, Riverside

Bio

Brandon Brown is an Associate Professor in the Department of Social Medicine, Population and Public Health at the University of California, Riverside (UCR) School of Medicine (SOM). His primary research interests include the health impacts of aging with HIV and ethical issues in HIV research. He has received funding from both private and federal organizations, working closely with community partners in every step of the research process. The first in his family to attend college, Dr. Brown earned his bachelor’s degree in applied mathematics from the University of California, Irvine, followed by a MPH in epidemiology from UCLA. He then attended the Johns Hopkins Bloomberg School of Public Health to earn his PhD in international health with a focus on epidemiology. After returning from his dissertation studies in Peru, he conducted postdoctoral work at UCLA. Dr. Brown received additional training as a HIV Prevention Trials Network (HPTN) Scholar, a Resource Center for Minority Aging Research Scholar, trainee at the Fordham HIV Research Ethics Training Institute (RETI), and visiting scholar at the Hastings Center for Bioethics. Dr. Brown is the Chair of the Board of Directors of TruEvolution, a non-profit organization advocating for health equity and racial justice for LGBTQ+ people; faculty advisor for the UCR Louis Stokes Alliance for Minority Participation program; equity advisor for the SOM; faculty member at RETI; member of the APHA Nations Health Advisory Board; and member of the HPTN ethics working group. His recent grants focus on developing a virtual village to halt isolation of people aging with HIV, and investigating payment practices in clinical research. With more than 140 publications, Dr. Brown is an avid collaborator and a highly sought-after epidemiologist for the media on topics related to COVID-19, having appeared in well over 100 outlets, including NPR, Time Magazine, and the Atlantic. 

Alejandra Casillas, MD, MSHS

Alejandra Casillas, MD, MSHS

Assistant Professor of Medicine in Residence, David Geffen School of Medicine, University of California, Los Angeles

Bio

Alejandra Casillas MD, MSHS is an assistant professor of medicine in residence, in the Division of General Internal Medicine and Health Services Research at the David Geffen School of

Medicine at UCLA. She practices primary care at UCLA, and also teaches medical students and internal medicine residents while caring for patients at the Venice Family Free Clinic. As the daughter of Mexican immigrants, Dr. Casillas witnessed the health disparities lived by her family, and the struggle for a better life in her diverse Los Angeles community. Today, as a primary care physician for the underserved, a mentor to trainees from disadvantaged backgrounds, and a health disparities researcher, she addresses these inequities.

The first in her family to attend college, Dr. Casillas completed her undergraduate studies at Harvard College and medical training at Harvard Medical School, where she received the Dean’s Community Service Award and was a Paul and Daisy Soros Scholar for New Americans. She finished her internal medicine and primary care residency at the University of California San Francisco, also serving as Chief Medical Resident at UCSF Medical Center. Dr. Casillas returned to Los Angeles as a Robert Wood Johnson Clinical Scholar at UCLA– where she completed a health services research and leadership fellowship, and received a masters’ degree at the Fielding School of Public Health. After completing her training, Dr. Casillas worked at the academic medical centers in Geneva and Lausanne, with funding from the Swiss Office of Public Health, to address immigrant health disparities in the French-speaking region of Switzerland.

Dr. Casillas’ health services research focuses on the low-income communities served by the Los Angeles County Department of Health Services, the second largest municipal safety net in the US, developing digital health interventions tailored to socially complex, Limited English Proficient patients. Her published scholarship also includes research and programming initiatives addressing equity and diversity inclusion in academia and health, connecting to her UCLA roles as director of the CTSI Health Disparities Student Research Program, and founder of the First Generation Program at the School of Medicine.

Christopher R. Cogle, MD

Christopher R. Cogle, MD

Professor of Hematology and Oncology, University of Florida

Bio

Christopher R. Cogle, M.D. is a physician, scientist, and professor of hematology and oncology at the University of Florida. Through mentored career awards from the National Institutes of Health(NIH K08) and the American Society of Clinical Oncology, he discovered that adult blood stem cells make blood vessels. He used that discovery to invent and patent new therapeutics for patients with blood cancers and cardiovascular diseases. He has been named a Top 10 Young Stem Cell Scientist by the British Council, a Scholar in Clinical Research by The Leukemia & Lymphoma Society, and his clinic has been designated a Center of Excellence by The Myelodysplastic Syndromes Foundation. He founded two startup companies, CancerPOP and addon, based on his inventions. Civic engagement is a priority for Dr. Cogle beginning in his early days in Scouting. He is currently a Den Leader in his children’s Cub Scout Pack. He has produced two documentaries–“The Gap” and “A Narrow Catch”–that shed light on systemic injustices in the American health system. Dr. Cogle led the State of Florida’s effort in crafting and implementing the Florida Cancer Plan, as elected Chairperson of the Florida Cancer Control and Research Advisory Council. As a National Academy of Medicine Emerging Leader in Health and Medicine Scholar, Dr. Cogle will expand his health policy efforts by focusing on national and international challenges in health promotion, disease prevention, and disease control.

Paul Cohen, MD, PhD

Paul Cohen, MD, PhD

Albert Resnick, M.D. Associate Professor, The Rockefeller University

Bio

Paul Cohen is the Albert Resnick, MD Associate Professor and Head of the Laboratory of Molecular Metabolism at the Rockefeller University. He is also a cardiologist at Memorial Sloan Kettering Cancer Center. He is a graduate of the Tri-Institutional MD-PhD Program, where he completed his PhD research with Dr. Jeffrey Friedman studying the unique metabolic effects of the hormone, leptin. He then pursued clinical training in Internal Medicine at Columbia and in Cardiology at Brigham and Women’s Hospital. He completed postdoctoral research training with Dr. Bruce Spiegelman at Dana Farber Cancer Institute studying transcriptional determinants of adipocyte identity. Dr. Cohen’s lab focus on understanding the molecular links between obesity and associated diseases with a particular focus on diabetes, cardiovascular disease, and cancer.

Carrie H. Colla, PhD

Carrie H. Colla, PhD

Associate Professor, The Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth

Bio

Dr. Carrie Colla is an Associate Professor of The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine. A health economist, Dr. Colla focuses on provider payment, health insurance markets, and insurance benefit design. Her work is aimed at improving the quality, accessibility, and cost of health care. Colla’s investigator-initiated research is dedicated to examining health system performance and the effectiveness of payment and delivery system reforms, including accountable care organizations. Her empirical studies include the effects of changes in Medicare reimbursement for physicians and institutional providers on vulnerable patient populations; the prevalence and drivers of low-value health care services; and labor market effects of health insurance expansions, among others. In 2017-2018 Dr. Colla participated in the Robert Wood Johnson Health Policy Fellowship, with placements in the House of Representatives and the Center for Medicare and Medicaid Innovation. Colla received her undergraduate degree from Dartmouth College, and her MA in economics and PhD in health policy from the University of California, Berkeley.

Justin Basile Echouffo Tcheugui, MD, PhD

Justin Basile Echouffo Tcheugui, MD, PhD

Assistant Professor of Medicine, Johns Hopkins University School of Medicine

Bio

Justin is a physician-scientist. He trained in clinical endocrinology and metabolism at Harvard University, USA. He underwent research training in epidemiology at the University of Cambridge, UK. and in clinical \investigation at Boston University, USA. He is currently an Assistant Professor of Medicine at the Johns Hopkins School of Medicine.

His clinical practice focuses on diabetes and obesity. His research is at the intersection of metabolism and cardiovascular diseases, exploring the pathways leading to type 2 diabetes, as well as the related-cardiovascular complications. He uses epidemiological methods and other investigational approaches (biomarkers, imaging, etc.) to understand the natural history and pathogenesis of diabetes and the resultant cardiovascular complications.

Oluwadamilola “Lola” Fayanju, MD, MA, MPHS

Oluwadamilola “Lola” Fayanju, MD, MA, MPHS

Helen O. Dickens Presidential Associate Professor of Surgery, Perelman School of Medicine, University of Pennsylvania

Bio

Dr. Fayanju is the inaugural Helen O. Dickens Presidential Associate Professor of Surgery in the Perelman School of Medicine at the University of Pennsylvania and the Chief of Breast Surgery for the University of Pennsylvania Health System. She is also be Surgical Director of the Rena Rowan Breast Center and an Innovation Faculty member at the Penn Center for Cancer Care Innovation (PC3I) in the Abramson Cancer Center. She is an academic breast surgical oncologist whose research focuses on health disparities, aggressive breast cancer variants, and improving value in oncology. She received her undergraduate degree in History and Science and an MA in Comparative Literature from Harvard. She received her MD and a master’s of population health sciences (MPHS) from Washington University in St. Louis, where she also completed her residency in General Surgery. She completed fellowship training in Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center. In 2019, she was recognized by the National Academy of Medicine as an Emerging Leader in Health and Medicine Scholar. Her research is supported by funding from the National Institutes of Health (NIH) and has been published in a variety of journals including Annals of Surgery, Cancer, and JAMA.

Anna Greka, MD, PhD

Anna Greka, MD, PhD

Associate Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School; Broad Institute of MIT and Harvard

Bio

With a focus on laying the foundation for molecularly targeted therapies, Anna Greka’s scientific work is centered on understanding membrane proteins and fundamental mechanisms of disrupted cellular homeostasis.

Anna’s early scientific work focused on the role of TRP ion channels in essential cellular functions. Combining her expertise in ion channel biology with the study of kidney podocytes, she uncovered a pathway linking TRPC5 ion channel activity to cytoskeletal dysregulation and cell death. Based on these discoveries, TRPC5 inhibitors are now being tested in the clinic for difficult-to-treat kidney diseases.

Recently, Anna and her team made a key discovery of a general mechanism that monitors the quality of membrane protein cargoes destined for the cell surface by studying a proteinopathy in the kidney, caused by a mutation in MUC1. Specifically, they identified a mechanism for membrane protein quality control that is operative in diverse cell types and tissues, such as kidney epithelial cells and retina photoreceptors. The study of cargo quality control and its implications for several toxic proteinopathies is now a major focus of the laboratory.

Anna is also interested in dissecting the fundamental mechanisms of disrupted cellular homeostasis at the intersection of proteotoxicity and lipotoxicity across the lifespan, with implications for many metabolic and degenerative human diseases.

Anna is the recipient of several honors, including the 2020 Donald W. Seldin Young Investigator Award by the American Society of Nephrology and the American Heart Association, the 2018 Seldin-Smith Award for Pioneering Research from the American Society of Clinical Investigation (ASCI), a 2017 Presidential Early Career Award for Scientists and Engineers, a 2014 Top 10 Exceptional Research Award from the Clinical Research Council, and a 2014 Young Physician-Scientist Award from the ASCI. She was also elected to the ASCI Council, and serves on the Harvard-MIT M.D.-Ph.D. Program Leadership Council.

Kelli Stidham Hall, PhD, MS

Kelli Stidham Hall, PhD, MS

Associate Professor, Heilbrunn Department of Population & Family Health, Mailman School of Public Health, Columbia University; Associate Professor, Rollins School of Public Health, Emory University

Bio

Dr. Kelli Stidham Hall is an Associate Professor in the Heilbrunn Department of Population & Family Health at Columbia University’s Mailman School of Public Health and adjunct Associate Professor with tenure at Emory University’s Rollins School of Public Health. She completed her PhD from Columbia University, a postdoctoral fellowship at Princeton University, and a NIH “BIRCWH” K12 Faculty Career Development Award at the University of Michigan. She is the Founding Director and Principal Investigator of the Center for Reproductive Health Research in the SouthEast (RISE) at Emory. Dr. Hall’s NIH-and foundation-funded program uses biosocial and multi-level frameworks and interdisciplinary methods to study the social determinants of reproductive health and health disparities in the U.S. and Africa. One major research theme entails evaluating the effects of policies and other macrosocial factors on family planning service delivery, access to care and outcomes. Her >15 years of clinical experience as a primary care advanced practice nurse informed her other theme focused on understanding and addressing interrelationships between reproductive, mental and behavioral health and social wellbeing during adolescence and young adulthood. She serves on the Board of Directors of the Society for Family Planning; Editorial Board of Contraception journal; Executive Committee of the National Medical Committee of Planned Parenthood Federation of America, and formerly as Section Counselor for APHA’s Population, Sexual and Reproductive Health (PSRH) Section. Dr. Hall was awarded APHA PSRH’s Outstanding Young Professional and the Society of Adolescent Health and Medicine’s Robert DuRant Statistical Rigor and Scientific Innovation in Adolescent Health Research Award.

Sidney H. Hankerson, MD, MBA

Sidney H. Hankerson, MD, MBA

Assistant Professor of Psychiatry, Columbia University Irving Medical Center

Bio

Sidney Hankerson, MD, MBA is Co-Director of the Columbia University Wellness Center, Associate Professor of Psychiatry at Columbia University Irving Medical Center, and an Attending Psychiatrist at New York-Presbyterian Hospital. His NIH-funded research focuses on reducing racial/ethnic disparities in mental health treatment. He is a nationally recognized expert at faith-based mental health services research and has presented his study results at the White House, United Nations, National Institute of Mental Health, Substance Abuse and Mental Health Services Administration, Gracie Mansion (NYC Mayor’s Office), and numerous national academic conferences. He was an inaugural member of the American Psychiatric Association’s (APA) Council of Faith and Community Partnerships and served on the APA Council of Minority Mental Health and Health Disparities.

Dr. Hankerson completed a dual MD/MBA program from Emory University, where he was Medical School Class President for two years. He completed his psychiatry residency at Emory and was named Chief Resident of Psychiatry at Grady Memorial Hospital. He then completed a NIMH T32 post-doctoral research fellowship at Columbia University.

Ronald L. Hickman, Jr., PhD, RN, ACNP-BC, FNAP, FAAN

Ronald L. Hickman, Jr., PhD, RN, ACNP-BC, FNAP, FAAN

The Ruth M. Anderson Endowed Chair and Associate Dean for Research, Frances Payne Bolton School of Nursing, Case Western Reserve University

Bio

Ronald Hickman is the inaugural Ruth M. Anderson Endowed Chair and Associate Dean for Research at the Frances Payne Bolton School of Nursing at Case Western Reserve University (CWRU). He is a registered nurse and a board-certified acute care nurse practitioner who has provided postoperative care for critically ill patients and their families. As a nurse scientist, Dr. Hickman is nationally known for his pioneering work focused on technology-based solutions to improve chronic disease self-management and end-of-life care. His innovative work integrates knowledge from several disciplinary domains to develop technologies and understand biobehavioral mechanisms that influence how patients and their families make decisions and manage their health or an acute illness. He is currently the principal investigator for an NIH-funded clinical trial evaluating the effects of a decision support technology for family members of critically ill patients posed with end-of-life care decisions.

Dr. Hickman received his PhD in nursing science from CWRU and completed a 4-year career development award (KL2) in multidisciplinary clinical and translational research at CWRU’s School of Medicine. Dr. Hickman’s scholarship has garnered numerous regional and national awards from research and professional societies, such as distinguished scientist awards and recognition for his efforts to enhance diversity and inclusion in nursing. He is committed to mentoring others and has received his university’s highest honors for excellence in mentoring undergraduates and graduate students. Dr.Hickman is an elected fellow of the National Academies of Practice and the American Academy of Nursing.

Ehsan Hoque, PhD

Ehsan Hoque, PhD

Assistant Professor of Computer Science; Affiliate faculty, Goergen Institute for Data Science, University of Rochester

Bio

Ehsan Hoque is an Asaro-Biggar (’92) Assistant Professor of Computer Science at the University of Rochester, where he co-leads the Rochester Human-Computer Interaction (ROC HCI) Group. From 2018-2019, he was the Interim Director of the Georgen Institute for Data Science.

Dr. Hoque uses Artificial Intelligence and Human-centered computing to amplify human ability. He models and captures the dynamics of human behavior using machine learning and network sciences; and design interactive systems to promote equality and access in health care. He has identified opportunities in developing technologies that can improve the lives of disadvantaged, ill, disabled, and other individuals who struggle with socio-emotional communication, such as those with autism, severe anxiety, neurodegenerative disease, and terminal illness.

His ideas and impact have been recognized by NSF CRII, NSF CAREER, and Early Career Award for Scientists and Engineers (ECASE). MIT Technology Review named him as one of the Top Innovators Under 35 (TR35) Award in 2016, and Science News recognized him as one of ten early-to mid-career scientists to watch in 2017. He is an inaugural member of the Association of Computing Machinery’s Future of Computing Academy (ACM FCA).

He earned his PhD from Massachusetts Institute of Technology in 2013, working with Prof. Rosalind Picard. His dissertation work of developing an intelligent agent to improve the socio-emotional ability of humans was highlighted by MIT Museum as one of MIT’s most unconventional inventions. He is blessed to be the primary caregiver of his brother, 20, diagnosed with autism and Down Syndrome.

Leora Horwitz, MD

Leora Horwitz, MD

Associate Professor, New York University School of Medicine

Bio

Dr. Leora Horwitz is director of the Center for Healthcare Innovation and Delivery Science at NYU Langone Health, director of the Division of Healthcare Delivery Science in the Department of Population Health at NYU School of Medicine, tenured associate professor of population health and of medicine, and a practicing internist. Her work focuses on improving the safety and quality of healthcare delivery. She conducts federally-funded research on transitions in care; develops quality measures for the Centers for Medicare & Medicaid Services; and leads the AHRQ-funded NYU Patient Imaging Quality and Safety Laboratory, the CMMI-funded Greater New York City Practice Transformation Network, the AHRQ-funded T32 Training Program in Population Health and Healthcare Delivery, and the philanthropically-funded Rapid Cycle RCT Lab. Dr. Horwitz received her undergraduate degree in Social Studies from Harvard and her medical degree from Harvard Medical School. She then completed residency and chief residency in internal medicine at Mt. Sinai Hospital in New York, NY and the Robert Wood Johnson Clinical Scholars Program at Yale. Dr. Horwitz was on faculty at Yale for 7 years before moving to NYU in 2014.

Mark Huffman, MD, MPH

Mark Huffman, MD, MPH

Quentin D. Young Professor of Health Policy and Associate Professor of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine; Associate Professor of Food Policy, The George Institute for Global Health

Bio

Dr. Mark Huffman is the Quentin D. Young Professor of Health Policy and Associate Professor of Preventive Medicine and Medicine-Cardiology at Northwestern University’s Feinberg School of Medicine. Huffman holds a secondary appointment as an Associate Professor of Food Policy at The George Institute for Global Health in Sydney, Australia. He is a practicing cardiologist, researcher, and teacher interested in global cardiovascular health epidemiology, clinical trials, implementation science, health systems and policy research, training, and action. Huffman serves as the director of Northwestern’s Center for Global Cardiovascular Health where his team works across the spectrum of cardiovascular disease prevention in research for improving acute cardiovascular systems of care, simplifying pharmacotherapy through fixed-dose combinations, programmatic implementation and evaluation for large-scale hypertension control, monitoring and improving the US and global food and medicine supplies, and achieving tobacco endgame. He aims to improve global cardiovascular health and health care, especially in low- and middle-income countries, and to bring lessons learned back home to the United States.

Ning (Jenny) Jiang, PhD

Ning (Jenny) Jiang, PhD

Peter & Geri Skirkanich Associate Professor of Innovation, University of Pennsylvania

Bio

Dr. Jenny Jiang is the Peter & Geri Skirkanich Associate Professor of Innovation of Bioengineering at University of Pennsylvania. She obtained her Ph.D. from Georgia Institute of Technology and received her postdoctoral training at Stanford University. Her research focuses on systems immunology and immune engineering by developing technologies that enable the direct profiling of human immune systems in various immunological diseases. Her work helped create the high-throughput immune repertoire profiling field. Dr. Jiang has received numerous awards including the NIH Pathway to Independence (K99/R00) Award, Cancer Prevention and Research Institute of Texas, Damon Runyon Cancer Research Foundation Damon Runyon-Rachleff Innovation Award, NSF CAREER Award, and Chan Zuckerberg Initiative Neurodegeneration Challenge Network Ben Barres Early Career Acceleration Award. She is also a Fellow of the American Institute for Medical and Biological Engineering.

Caprice Knapp, PhD

Caprice Knapp, PhD

Medicaid Director, State of North Dakota

Bio

In August 2019, Caprice Knapp became the North Dakota Medicaid Director. She brings to the position more than 17 years’ experience working on Medicaid and CHIP in the private sector, state and federal policymaking, and academics. In the private sector, she was the federal policy director for Molina Healthcare, Inc. In academics, she was an Associate Professor in the Department of Health Outcomes and Policy at the University of Florida (UF) conducting external quality review activities for Texas and Florida Medicaid and CHIP programs and maternal and child health research. In the policymaking arena, she worked in the Governor’s Office of State Planning and Budgeting in Colorado as well as the U.S.House of Representatives Energy and Commerce Committee as a Robert Wood Johnson Health Policy Fellow.

Knapp’s career has been focused on vulnerable populations, delivery system reform, and global health.Examples of her funded research topics include an assessment of Florida’s Children’s Health Insurance Program Reauthorization Grant; an evaluation of fertility-preservation decision making for adolescent girls with cancer; outcomes of concurrent models of pediatric palliative care; and an assessment of the quality, patient experiences, and costs of health and dental plans for children in Florida. Her global health projects also focus on maternal and child health and have been conducted in Africa, Asia, Europe, and South America. At the University of Florida, Knapp earned a PhD in economics and completed postdoctoral training in health services research. She has authored more than 80 peer-reviewed publications, 60 government reports, and two books.

Joseph A. Lewnard, PhD

Joseph A. Lewnard, PhD

Assistant Professor of Epidemiology, University of California, Berkeley

Bio

Dr. Lewnard is an Assistant Professor of Epidemiology at the University of California, Berkeley School of Public Health. He studies the transmission dynamics and control of infectious disease agents, with a focus on respiratory and vaccine-preventable pathogens. Through multiple projects involving government, NGO, public health and industry collaborations, his lab has established pediatric vaccines as one of the most promising tools for addressing the global challenges of antimicrobial overuse and resistance. Since 2020, he has also made numerous contributions to the ongoing COVID-19 response, and leads multiple ongoing field-based studies in California as well as large-scale studies of COVID-19 epidemiology in South India. He was the 2021 recipient of the Early Career Research Excellence award from the Association of Schools and Programs of Public Health, a 2019 fellow of the Kavli Frontiers in Science program of the National Academy of Sciences, and a member of the 2018 Emerging Leaders in Biosecurity fellowship cohort at the Johns Hopkins Center for Health Security. He received his PhD in Epidemiology of Microbial Diseases from Yale University in 2017 and was a postdoc from 2017-18 at Harvard TH Chan School of Public Health. He received a BA with first class honors in Geography and Music from McGill University in 2013. He serves on the editorial board of eLife and during the 2021-22 year holds a visiting Medical Officer appointment in the Influenza Division of the CDC. He is the recipient of extramural research grants from NIH, the Bill & Melinda Gates Foundation, the Wellcome Trust, WHO, CDC, Pfizer, Merck, the US-Israel Binational Science Foundation, and other funders.

Miguel Marino, PhD

Miguel Marino, PhD

Associate Professor of Biostatistics, Oregon Health & Science University

Bio

Miguel Marino, PhD is an Associate Professor of Biostatistics in the Department of Family Medicine at Oregon Health & Science University, with a secondary appointment in the OHSU-PSU School of Public Health. He received his undergraduate degree in Mathematics from UCLA and his PhD from Harvard University. Before joining OHSU, he was a Yerby Postdoctoral Fellow at Harvard University.

Dr. Marino maintains a broad statistical research program that focuses on the intersection of primary care and public health studies. His research utilizes novel statistical methodology to address complexities associated with the use of electronic health records (EHRs) for critical community and primary care research questions in health policy, health disparities, preventive service utilization, health insurance monitoring, among others. Dr. Marino currently studies how to validate EHRs as a reliable source for pragmatic trials and observational cohort studies. He is currently funded by several agencies including the NIH, AHRQ, CDC and has over 125 peer-reviewed publications in scientific journals such as JAMA, JGIM, Health Affairs, and AJPH.

Since 2013, Dr. Marino has been the Statistical Editor for the Annals of Family Medicine. He also has served on NIH, PCORI and AHA study sections. He has formerly served as the President of the American Statistical Association’s Oregon Chapter. Currently, he serves as the Publications Officer for the Health Policy Statistics section of the American Statistical Association. His contributions to this field were recognized in 2017 when he received the New Investigator Research Award by the North American Primary Care Research Group.

Mark Neuman, MD

Mark Neuman, MD

Associate Professor of Anesthesiology and Critical Care, University of Pennsylvania

Bio

Mark D. Neuman is Associate Professor of Anesthesiology and Critical Care at the University of Pennsylvania Perelman School of Medicine and Senior Fellow at the Leonard Davis Institute of Health Economics. Dr. Neuman is the founding Director of the Penn Center for Perioperative Outcomes Research and Transformation, which focuses on improving the health and well-being of patients undergoing surgery, critical care, and pain treatment through comparative effectiveness research and implementation science. A practicing general anesthesiologist and health services researcher, his work has been supported by the National Institutes of Health (NIH), the Patient-Centered Outcomes Research Institute (PCORI), and the Foundation for Anesthesia Education and Research. Dr. Neuman’s work, which has appeared in JAMA, the Lancet, the BMJ, and the New England Journal of Medicine, focuses primarily on understanding the determinants of functional outcomes among older adults undergoing major surgical procedures and the short- and long-term consequences of anesthetic and pain management interventions delivered around the time of surgery; additional work has examined processes by which medical research findings are translated into expert guidelines, and how such guidelines change over time in response to new evidence. He is the Principal Investigator of the PCORI-funded REGAIN trial (Regional versus General Anesthesia for Promoting Independence after Hip Fracture), a 45-center international pragmatic randomized trial to assess the association between commonly used anesthesia treatments for older adults undergoing hip fracture repair with and survival and functional outcomes at up to 1 year after fracture. Dr. Neuman currently chairs the Committee on Geriatric Anesthesia of the American Society of Anesthesiologists and lectures nationally and internationally on the care of older adults undergoing surgery and anesthesia and on the design and conduct of pragmatic trials in perioperative care.

Ziad Obermeyer, MD

Ziad Obermeyer, MD

Acting Associate Professor of Health Policy and Management, University of California, Berkeley

Bio

Ziad Obermeyer is an Associate Professor (Acting) at UC Berkeley, where he does research at the intersection of machine learning, medicine, and health policy. Previously, he was an Assistant Professor at Harvard Medical School. He has received numerous awards including the Early Independence Award, the National Institutes of Health’s most prestigious award for exceptional junior scientists, and the Young Investigator Award from the Society for Academic Emergency Medicine. His work has been published in Science, The New England Journal of Medicine, JAMA, The BMJ, and Health Affairs. He is a graduate of Harvard College (magna cum laude) and Harvard Medical School (magna cum laude) and earned an M.Phil. from Cambridge in the history and philosophy of science. Prior to his career in medicine, he worked as a consultant to pharmaceutical and global health clients at McKinsey & Co. in New Jersey, Geneva, and Tokyo. He continues to practice emergency medicine in underserved communities.

Brea Perry, PhD

Brea Perry, PhD

Professor of Sociology, Indiana University

Bio

Dr. Brea Perry is a Professor in the Department of Sociology and the Network Science Institute at Indiana University. Her research investigates the interrelated roles of social networks, biomarkers, social psychology, and social inequality as cause and consequence of health and illness. Her work often focuses on psychological and brain diseases, including neurological disorders common in aging, mental illness, and substance use disorders. Dr. Perry’s current projects (funded by the National Institutes of Health and the National Science Foundation) examine: 1) the social dynamics of high-risk drug-seeking behavior as a predictor of opioid overdose and related outcomes; 2) poverty, social network dynamics, and health services use among health care “super utilizers” with complex, comorbid conditions; 3) relationships between personal social network structure and function, cognitive decline, and neuroimaging biomarkers in the aging brain; 4) and changes in recent immigrants’ health behaviors and outcomes as a function of acculturation and social network characteristics. These interdisciplinary projects leverage her expertise in social network analysis, survey research design and data collection, and longitudinal and multilevel modeling. In addition to authoring a book on ego network methodology (Cambridge University Press, 2018), Dr. Perry has published two edited volumes and 54 peer-reviewed papers. She has received funding from multiple National Institutes of Health, including NIDA, NIDCR, NIA, and NCRR, as well as the National Science Foundation and several charitable foundations. She is currently Chair of the American Sociological Association’s Section on Medical Sociology, and Series Editor of Advances in Medical Sociology. She received her PhD in Sociology from Indiana University in 2008.

Nathan Price, PhD

Nathan Price, PhD

CEO, Onegevity

Bio

Dr. Nathan Price is the CEO of Onegevity, a division of Thorne HealthTech. He is also a (on leave) Professor at the Institute for Systems Biology, where he co-directs with Lee Hood the Hood-Price Lab for Systems Biomedicine. Additionally, Dr. Price is an affiliate faculty at the University of Washington in the Departments of Bioengineering, Computer Science & Engineering, and Molecular & Cellular Biology. 

Price has received a number of awards for his research work, including an American Cancer Society Postdoctoral Fellowship, a Howard Temin Pathway to Independence Award from the National Institutes of Health (NIH), a National Science Foundation (NSF) CAREER award, a young investigator award from the Roy J. Carver Charitable Trust, and being named as one of the inaugural “Tomorrow’s PIs” by Genome Technology. He was also named as a Camille Dreyfus Teacher-Scholar, and received the 2016 Grace A. Goldsmith Award for his work pioneering scientific wellness. 

Price co-founded Arivale, a scientific wellness company that was named as Geekwire’s 2016 startup of the year. He is a member of the Board of Trustees of the Health and Environmental Sciences Institute (HESI) and on the Board of Advisors for the American Cancer Society (WA).  He was also Chair of the NIH study section on Modeling and Analysis of Biological Systems (MABS). 

Price also has served on numerous scientific advisory boards including for Providence St. Joseph Health, Roche (personalized healthcare division), Sera Prognostics, Navican, Basepaws, and the Novo Nordisk Foundation Center for Biosustainability. He is a fellow of the European Society of Preventive Medicine, and has published over 180 scientific papers and given over 200 invited talks.

Christina Ann Roberto, PhD

Christina Ann Roberto, PhD

Mitchell J. Blutt and Margo Krody Blutt Presidential Associate Professor of Health Policy, University of Pennsylvania

Bio

Christina A. Roberto, Ph.D. is the Mitchell J. Blutt and Margo Krody Blutt Presidential Associate Professor of Health Policy at the Perelman School of Medicine at the University of Pennsylvania. She is also the Director of the Psychology of Eating and Consumer Health lab (PEACH lab) and Associate Director of the Center for Health Incentives and Behavioral Economics at Penn. The mission of the PEACH lab is to identify and evaluate policies and interventions that promote healthy eating habits and prevent nutrition-related chronic diseases. The lab strives to help create a just and equitable food system where those with the fewest resources and opportunities have the same chance to live a long, healthy life as those with the most. The PEACH lab’s work has informed local and national government food policy. Dr. Roberto works closely with policymakers, community-based organizations, companies, and institutions to generate timely research that can provide those partners with science-based guidance.

Dr. Roberto has an undergraduate degree in Psychology from Princeton University where she graduated magna cum laude. She earned a joint-PhD at Yale University in clinical psychology and chronic disease epidemiology. Dr. Roberto completed her clinical internship at the Yale School of Medicine and was a Robert Wood Johnson Foundation Health and Society Scholar at the Harvard T.H. Chan School of Public Health.

Hassan A. Tetteh, MD, MBA, MPA, MS

Hassan A. Tetteh, MD, MBA, MPA, MS

Chief Medical Informatics Officer, United States Navy Associate Professor of Surgery, Uniformed Services University of the Health Sciences

Bio

Dr. Hassan A. Tetteh is a US Navy Captain and Associate Professor of Surgery at the Uniformed Services University of the Health Sciences and adjunct faculty at Howard University College of Medicine. He was a Robert Wood Johnson Health Policy Fellow from 2012-13, assigned to the US Congress, Congressional Budget Office, (CBO). Currently, Tetteh is a Thoracic Surgeon for MedStar Health and Walter Reed National Military Medical Center. He leads a Specialized Thoracic Adapted Recovery (STAR) Team, in Washington, DC, and his research in thoracic transplantation aims to expand heart and lung recovery and save lives.

A native of Brooklyn, New York, Tetteh received his BS from State University of New York (SUNY) at Plattsburgh, his MD from SUNY Downstate Medical Center, his MPA from Harvard’s Kennedy School of Government, MBA from Johns Hopkins University Carey Business School, and MS in National Security Strategy with a concentration in Artificial Intelligence from the National War College. He completed his thoracic surgery fellowship at the University of Minnesota and advanced cardiac surgery fellowship at Harvard Medical School’s Brigham and Women’s Hospital in Boston.

Tetteh is a bestselling author of the novel Gifts of the Heart, has finished twenty marathons, and recently delivered the popular TEDx talk entitled, From Death to Life, based on his work in transplant surgery. Tetteh is board certified in thoracic surgery, general surgery, clinical informatics, and healthcare management, and is a Fellow of the American College of Surgeons and Fellow of the American College of Healthcare Executives.

Brownsyne Tucker Edmonds, MD, MPH, MS

Brownsyne Tucker Edmonds, MD, MPH, MS

Vice President and Chief Health Equity Officer, Indiana University Health; Associate Professor of Obstetrics and Gynecology and Clinical Pediatrics, and Associate Dean for Health Equity Research, Indiana University

Bio

Brownsyne Tucker Edmonds is the inaugural Vice President and Chief Health Equity Officer for Indiana University Health and the Associate Dean for Health Equity Research for Indiana University School of Medicine (IUSM), where she holds an endowed chair for Health Equity Research.  She is an Associate Professor of Obstetrics Gynecology (OB/GYN) and Clinical Pediatrics with training in general OB/GYN, health services research, public health, and clinical ethics.  Her research interests are in patient-provider communication and shared decision-making in reproductive health care. She is interested in understanding the impact of race, class, and culture on patient preferences and risk perceptions; physician decision-making and counseling; and ultimately, variations in treatment provision and service delivery. Dr. Tucker Edmonds’ work currently focuses on communication and decision-making in the management of periviable deliveries. She utilizes qualitative and quantitative methodologies to develop decision support interventions for parents facing this, and other, preference sensitive decisions in high-risk obstetrical settings. Dr. Tucker Edmonds previously served as her department’s Vice Chair for Faculty Development and Diversity, and also served as an Assistant Dean for Diversity Affairs for the IU School of Medicine.  Dr Tucker Edmonds previously served on the Ethics Committee for the American College of Obstetrics and Gynecology (ACOG) and was the Legislative Affairs Chair for Indiana ACOG.  She now serves on ACOG’s Committee on Government Affairs and is the Chair of the Indiana Section.  Dr. Tucker Edmonds was an Anniversary Fellow for the National Academy of Medicine (NAM) from 2015-2017, during which time she served on the committee that authored, “The health effects of cannabis and cannabinoids: The current state of the evidence and recommendations for research.”  Most recently, she served on the committee that authored the consensus report, “Birth Settings in America: Outcomes, Quality, Access, and Choice.”

Jing Wang PhD, MPH, MSN, RN, FAAN

Jing Wang PhD, MPH, MSN, RN, FAAN

Dean and Professor, Florida State University

Bio

Jing Wang, PhD, MPH, RN, FAAN is the new Dean and Professor of the Florida State University College of Nursing, and Adjunct Professor in Biomedical Informatics at the University of Texas Health Science Center at Houston. Her research uses mobile and connected health technologies to optimize multiple-behavior lifestyle interventions and improve patient-centered outcomes among the chronically ill and aging populations with multiple chronic conditions, especially among the rural, underserved, and minority populations. Recently, she led interdisciplinary research that uses artificial intelligence to develop health care data analytics methods to characterize the dynamic pathways to the emergence of common multiple chronic conditions in Latinx populations and optimize multiple-behavior intervention through smart and adaptive clinical trials. In addition to her research focus on health disparity populations, she’s also devoted to Diversity, Equity, and Inclusivity in academic and clinical nursing settings as President-Elect of the Asian American/Pacific Islander Nurses Association, and Board of Directors at National Coalition of Ethnic Minority Nurses Association.She’s an elected Fellow of the American Academy of Nursing, 2013 Robert Wood Johnson Foundation Nurse Faculty Scholar, 2015 TEDMED Scholar, 2016 Josiah Macy Jr. Foundation Macy Faculty Scholar, and Harvard Macy Scholar where she continues to teach in the “Leading Innovations in Health Care & Education” program in the Harvard Macy Institute. She is also the editorial board member of the Diabetes Educator and the Editor-in-Chief of JMIR Aging. She was a member of the Steering Committee that updated the American Nurses Association (ANA) Connected Health Principles from the 1998 ANA Core Principles on Telehealth to guide nursing practice on telehealth and connected health. As a Health and Aging Policy Fellow and American Political Science Association Congressional Fellow, she works with Centers for Medicare & Medicaid Services (CMS), serves as a Senior Scientific Advisor to Agency for Healthcare Research and Quality (AHRQ), and will work with the Office of the National Coordinator for Health Information Technology (ONC) as a senior policy advisor. Wang received MSN and PhD from the University of Pittsburgh School of Nursing, MPH from its Graduate School of Public Health, and Graduate Certificate in Clinical and Translational Science from its School of Medicine.

Keegan Warren-Clem, JD, LLM

Keegan Warren-Clem, JD, LLM

Director and Managing Attorney, Medical-Legal Partnerships at Texas Legal Services Center; Adjunct Professor, The University of Texas School of Law and McCombs School of Business

Bio

Keegan Warren-Clem, JD, LLM, is the director and managing attorney of Medical-Legal Partnerships (MLP) at Texas Legal Services Center. Through MLPs at multiple health care sites, she works collaboratively with health care providers to improve health outcomes by bringing patient-centered legal and structural expertise into the delivery of health care. An adjunct professor dually appointed at The University of Texas School of Law and McCombs School of Business, Keegan also challenges students and residents to explore connections between health and unmet legal needs. Currently, Keegan is engaged in research that takes an epidemiological approach to legal interventions as a concrete means for addressing social determinants of health, and she recently finished service on a National Academy of Medicine committee on integrated health care delivery. Keegan is admitted to practice in Texas and is a member of the State Bar College, an honorary society of the most highly trained lawyers in the state. She is a veteran of the Army National Guard and is also a member of the Order of St. Joan of Arc, the highest civilian award given by the Army Armor and Cavalry Associations. Keegan earned her LLM in Health Law and Policy as the inaugural Southern Illinois Healthcare/Southern Illinois University MLP LLM Fellow, her JD from The University of Texas, and her BA in Spanish, international relations, and Latin American studies from the University of Arkansas as a Sturgis Fellow. In her spare time, she rows crew.

Jeffrey K. Wickliffe, PhD, MS

Jeffrey K. Wickliffe, PhD, MS

Professor and Chair, Department of Environmental Health Sciences, School of Public Health, University of Alabama at Birmingham

Bio

Dr. Jeffrey K. Wickliffe is Professor and Chair in the Department of Environmental Health Sciences in the School of Public Health at the University of Alabama at Birmingham. His research focuses on the complex interplay among environmental health risk factors and their impacts on human health at the population level. His work is concerned with environmental exposures that result in chronic disease outcomes such as cancers as well as exposures that occur during fetal development and their effects on perinatal health including neurodevelopmental outcomes. His work also incorporates underlying health status in evaluating the likelihood of negative health effects upon exposure to environmental risk factors. A feature of his current work is focused on the relationship between overweight and obesity and the associated increased sensitivity to disease risk factors and disease prevalence. He has published numerous articles from bench experimental studies to population studies investigating the relationships between environmental exposures and their ultimate effects. His work clearly demonstrates his desire and ability to work within multidisciplinary teams to address increasingly complex population health and public health threats. His population work spans from local settings to international settings wherever environmental health problems exist.

His research has been funded by the National Institutes of Health including the National Institute of Environmental Health Sciences and the Fogarty International Center, the National Science Foundation, the Health Effects Institute and non-governmental foundations.

Jeff received his PhD from Texas Tech University and completed a 2-year, NIEHS-sponsored postdoctoral fellowship at the University of Texas Medical Branch. Jeff was a faculty member (Assistant and Associate Professor) in the Department of Environmental Health Sciences in the School of Public Health and Tropical Medicine at Tulane University from 2009 until 2020.

Emerging Leaders in Health and Medicine Scholars Alumni
  • Paul Christopher, PhD
  • Deidra C. Crews, MD, ScM
  • Adaeze Enekwechi, PhD
  • Lori Freedman, PhD
  • Christopher Friese, PhD, RN, AOCN, FAAN
  • Jordan Green, PhD
  • Marcia Haigis, PhD
  • Sandeep Kishore, MD, PhD, MSc
  • Raina Merchant, MD, MSHP
  • Mark Neuman, MD
  • Minal Patel, PhD, MPH
  • Suchi Saria, MSc, PhD
  • Margaret (Gretchen) L. Schwarze, MD, MPP
  • Julie Segre, PhD Sohail Tavazoie, MD, PhD
  • Julie Segre, PhD
  • Jacob Sherkow, JD
  • Hanni Stoklosa, MD, MPH
  • Sohail Tavazoie, MD, PhD
  • Y. Claire Wang, MD, ScD, MS
  • Jonathan Watanabe, PharmD, MS, PhD, BCGP
  • Joseph C. Wu, MD, PhD
  • Ramnik Xavier, MD, ChB

Join Our Community

Sign up for NAM email updates